Q1 EPS Forecast for United Therapeutics Lifted by Analyst
United Therapeutics Co. (NASDAQ:UTHR – Free Report) – Equities research analysts at Leerink Partnrs increased their Q1 2025 EPS estimates for United Therapeutics in a research note issued to investors on Friday, April 25th. Leerink Partnrs analyst R. Ruiz now forecasts that the biotechnology company will post earnings per share of $6.48 for the quarter, […]
United Therapeutics Co. (NASDAQ:UTHR – Free Report) – Equities research analysts at Leerink Partnrs increased their Q1 2025 EPS estimates for United Therapeutics in a research note issued to investors on Friday, April 25th. Leerink Partnrs analyst R. Ruiz now forecasts that the biotechnology company will post earnings per share of $6.48 for the quarter, […]
